Lou Scafuri, Syneron-Candela CEO, will present upcoming investor conferences

Louis P. Scafuri, Chief Executive Officer, is scheduled to present at two upcoming investor conferences.

The first presentation will be at the annual UBS Global Life Sciences Conference in New York City.

Event: UBS Global Life Sciences Conference
Date: Monday, September 19, 2011
Time: 9:30 a.m. ET

The second presentation will be at the JMP Securities Healthcare Conference in New York City.

Event: JMP Securities Healthcare Conference
Date: Wednesday, September 28, 2011
Time: 10:00 a.m. ET

The presentations will be webcast live over the Internet and can be accessed through the Investor Relations section on Syneron's website at www.syneron.com. Please go to the website a few minutes early, as it may be necessary to download audio software to hear the presentation.

 

 

 

See more in:

Syneron® manufactures and sells ablative and non-ablative medical aesthetic devices that use the patented elos technology with applications for treatment of wrinkles, skin, age spots, cellulite, acne, rosacea, hair removal, leg veins, spider veins, and much more.  elos technology combines radio frequency and light energies, and is sold to dermatologists, plastic surgeons, family practitioners and other physicians, aestheticians, and medical spa professionals around the world.